IL17A and systemic lupus erythematosus: Compared with the HCs, the patients with newly diagnosed SLE had notably decreased levels of plasma IL-35 (Fig. 2B) and significantly elevated levels of plasma IL-10 (Fig. 2A), IL-17 (Fig. 2C), TNF-α (Fig. 2D), and IFN-γ (Fig. 2E).